CRIS Current Research Information System

BARTOLETTI, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.058
AS - Asia 912
EU - Europa 704
AF - Africa 74
SA - Sud America 59
OC - Oceania 1
Totale 2.808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.043
SG - Singapore 364
CN - Cina 261
IT - Italia 131
SE - Svezia 118
DE - Germania 116
GB - Regno Unito 88
VN - Vietnam 82
HK - Hong Kong 66
IN - India 65
BR - Brasile 44
IE - Irlanda 43
RU - Federazione Russa 43
FR - Francia 38
CI - Costa d'Avorio 35
FI - Finlandia 34
NL - Olanda 30
KR - Corea 27
TG - Togo 22
CA - Canada 11
CH - Svizzera 10
ID - Indonesia 10
JO - Giordania 9
JP - Giappone 9
BE - Belgio 8
PL - Polonia 8
TR - Turchia 8
UA - Ucraina 8
BG - Bulgaria 7
ZA - Sudafrica 7
AT - Austria 6
EC - Ecuador 5
EE - Estonia 5
NG - Nigeria 4
AR - Argentina 3
BD - Bangladesh 3
CO - Colombia 3
MX - Messico 3
AZ - Azerbaigian 2
EG - Egitto 2
LT - Lituania 2
RO - Romania 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
AU - Australia 1
BB - Barbados 1
CZ - Repubblica Ceca 1
ES - Italia 1
GE - Georgia 1
GF - Guiana Francese 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
SC - Seychelles 1
UY - Uruguay 1
Totale 2.808
Salva come PNG Salva come JPEG
Città #
Singapore 262
Ashburn 160
Chandler 121
Southend 69
Fairfield 64
Hong Kong 64
Hefei 54
Santa Clara 49
Dublin 43
Beijing 40
Princeton 38
Dallas 37
Abidjan 35
Dong Ket 32
Los Angeles 29
Woodbridge 29
Helsinki 27
Houston 27
Seoul 27
Boardman 26
Bologna 26
Seattle 25
Wilmington 25
Cambridge 22
Lomé 22
Hyderabad 21
Munich 21
Milan 19
New York 18
Ann Arbor 17
Ho Chi Minh City 17
Hanoi 15
Redmond 15
Nanjing 13
Bremen 12
Buffalo 12
Berlin 11
Westminster 10
Amman 9
Bern 8
Brussels 8
Frankfurt am Main 8
Nuremberg 8
Turin 8
Jakarta 7
London 7
Sofia 7
Tokyo 7
Chicago 6
Des Moines 6
Phoenix 6
Redondo Beach 6
Bengaluru 5
Boydton 5
Guangzhou 5
Lappeenranta 5
Redwood City 5
Saint Petersburg 5
San Diego 5
San Francisco 5
Shenyang 5
São Paulo 5
Toronto 5
Warsaw 5
Abeokuta 4
Brooklyn 4
Changchun 4
Migliarino 4
Norwalk 4
Orem 4
Paris 4
Rome 4
Shanghai 4
Shijiazhuang 4
Stockholm 4
Vienna 4
Wayne 4
Wenzhou 4
Bari 3
Biên Hòa 3
Chennai 3
Ercolano 3
Falkenstein 3
Fuzhou 3
Mountain View 3
Olalla 3
Qingdao 3
The Dalles 3
Zhengzhou 3
Amsterdam 2
Andover 2
Baku 2
Catania 2
Central 2
Cernusco sul Naviglio 2
Council Bluffs 2
Da Nang 2
Falls Church 2
Fiesole 2
Guayaquil 2
Totale 1.826
Salva come PNG Salva come JPEG
Nome #
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib 188
Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients 187
Disease-specific derangement of circulating endocannabinoids and n-acylethanolamines in myeloproliferative neoplasms 187
Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis 162
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients 148
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis 129
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome 127
Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients 122
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib. 120
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 111
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis 111
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 106
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years. 105
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data 102
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis 101
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodies 99
The diagnostic role of next generation sequencing in uncovering isolated splenomegaly: A case report 92
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib 89
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia 84
Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID-19) pandemic: selection criteria and patients’ satisfaction 72
Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter Study 72
null 68
Longer-term response to SARS-CoV-2 vaccine in MPN patients: Role of ruxolitinib and disease severity 68
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients 66
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome 63
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎ 62
Spleen and Liver Fibrosis Is Associated to Treatment Response and Prognosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms 59
Totale 2.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.623
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021138 0 0 0 0 0 0 6 25 37 4 9 57
2021/2022349 5 13 13 33 25 18 8 32 16 31 91 64
2022/2023478 35 58 30 63 44 48 12 28 97 14 26 23
2023/2024173 9 38 18 18 14 22 2 14 4 15 8 11
2024/2025667 59 59 59 64 70 34 42 48 8 63 43 118
2025/2026804 149 122 150 119 164 94 6 0 0 0 0 0
Totale 2.900